Cancer, Obesity/Overweight and Insomnia Study
Completed · Not applicable
Conditions studied: Breast Cancer, Overweight and Obesity, Insomnia
In brief
This is a randomized pilot study to better understand the relationships among insomnia, weight loss, and breast cancer. This study will assess the effectiveness of a sleep intervention prior to a web- and phone-based weight loss program.
Key facts
- Study ID
- NCT03542604
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- People needed
- 30
- Starts
- 2018-06-12
- Expected to finish
- 2020-11-30
- Last updated by the study team
- 2020-12-16
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female
- 18 years of age or older
- Histologically-confirmed ductal carcinoma in-situ (DCIS) or stage I-III invasive carcinoma of the breast
- Current BMI ≥ 25 kg/m2 and weight ≤ 400 lbs
- Willing to lose 10% of body weight
- Diagnosed with current breast cancer >3 and <60 months from planned baseline visit date
- Completed local therapy (i.e. surgery and radiation therapy) and any planned preoperative or adjuvant chemotherapy within >3 prior to enrollment
- Diagnosed with insomnia or reports sleep problems
- Has daily access to the internet and/or smartphone
You may not qualify if…
- Serious/uncontrolled condition likely to hinder accurate measurement of weight or sleep, such as bipolar I, seizure disorders, autoimmune disease, etc., or a medical condition that makes physical activity unsafe
- Current use of weight loss medications or sleeping aids
- Current enrollment in a sleep or weight loss program
- Sleep disorder other than insomnia
- Plan to become pregnant within next 12 months, or lactating
Where it is running
- Johns Hopkins University, Bayview Medical Campus — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.